Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

The Obesity ETF (SLIM)

Delayed Data
As of May 10
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the performance, before fees and expenses, of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care and medical device companies whose business is focused on obesity and obesity related disease and companies focused on weight loss programs, weight loss supplements, or plus sized apparel. The fund invests at least 80% of its net assets in the stocks that comprise the Solactive Obesity Index. It is non-diversified.

No recent news for The Obesity ETF.


1 month+3.10% 3 years--
3 months+5.70% 5 years--
1 year-- Since inception-0.38%
Data through 05/20/2017

Quote Details

Previous close$24.32
Open day’s range-- – --
Net asset value (NAV)25.11 (05/19/2017)
Daily volume0
Average volume (3 months)1,510
Data as of 05/10/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+16.30%
Expense Gross exp ratio0.50%1.32%
Risk 5 year sharpe ratio--1.08
Net assets$2.5M$3.0B
Average market cap$4.6B$28.8B
Average P/E18.323.8
Dividend / Share--0.30%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 20.13%
-- 5.18%
HLF Herbalife Ltd4.97%
-- 4.59%
-- 4.56%
DVA Davita Inc4.52%
NXTM NxStage Medical Inc4.51%
-- 4.40%
LXRX Lexicon Pharmaceuticals Inc4.19%
PODD Insulet Corp4.17%